137 related articles for article (PubMed ID: 9135545)
1. Prevention of superantigen-induced down-regulation of T-cell mediated cytotoxic activity by IL-2 in vivo.
Belfrage H; Dohlsten M; Hedlund G; Kalland T
Immunology; 1997 Feb; 90(2):183-8. PubMed ID: 9135545
[TBL] [Abstract][Full Text] [Related]
2. Superantigens anergize cytokine production but not cytotoxicity in vivo.
Sundstedt A; Dohlsten M; Hedlund G; Höidén I; Björklund M; Kalland T
Immunology; 1994 May; 82(1):117-25. PubMed ID: 7913912
[TBL] [Abstract][Full Text] [Related]
3. Superantigen-induced anergy in cytotoxic CD8+ T cells.
Sundstedt A; Höidén I; Hansson J; Hedlund G; Kalland T; Dohlsten M
J Immunol; 1995 Jun; 154(12):6306-13. PubMed ID: 7759869
[TBL] [Abstract][Full Text] [Related]
4. Enhanced and prolonged efficacy of superantigen-induced cytotoxic T lymphocyte activity by interleukin-2 in vivo.
Belfrage H; Dohlsten M; Hedlund G; Kalland T
Cancer Immunol Immunother; 1995 Aug; 41(2):87-94. PubMed ID: 7656274
[TBL] [Abstract][Full Text] [Related]
5. Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment.
Belfrage H; Dohlsten M; Hedlund G; Kalland T
Cancer Immunol Immunother; 1997 Apr; 44(2):77-82. PubMed ID: 9177468
[TBL] [Abstract][Full Text] [Related]
6. Immune response during tumor therapy with antibody-superantigen fusion proteins.
Rosendahl A; Hansson J; Sundstedt A; Kalland T; Dohlsten M
Int J Cancer; 1996 Sep; 68(1):109-13. PubMed ID: 8895549
[TBL] [Abstract][Full Text] [Related]
7. Response of T cells in vivo induced by repeated superantigen treatments at different time intervals.
Huang Y; Sui Y; Zhang X; Si S; Ge W; Hu P; Li X; Ma B
Acta Biochim Biophys Sin (Shanghai); 2007 Jul; 39(7):467-74. PubMed ID: 17622466
[TBL] [Abstract][Full Text] [Related]
8. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
[TBL] [Abstract][Full Text] [Related]
9. Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity.
Belfrage H; Bhiladvala P; Hedlund G; Dohlsten M; Kalland T
Cancer Immunol Immunother; 1994 Apr; 38(4):265-71. PubMed ID: 8168122
[TBL] [Abstract][Full Text] [Related]
10. Interaction between superantigen and T-cell receptor Vbeta element determines levels of superantigen-dependent cell-mediated cytotoxicity of CD8(+) T cells in induction and effector phases.
Li ZJ; Omoe K; Shinagawa K; Yagi J; Imanishi K
Microbiol Immunol; 2009 Aug; 53(8):451-9. PubMed ID: 19659929
[TBL] [Abstract][Full Text] [Related]
11. Implantation of IL-2-containing osmotic pump prolongs the survival of superantigen-reactive T cells expanded in mice injected with bacterial superantigen.
Kuroda K; Yagi J; Imanishi K; Yan XJ; Li XY; Fujimaki W; Kato H; Miyoshi-Akiyama T; Kumazawa Y; Abe H; Uchiyama T
J Immunol; 1996 Aug; 157(4):1422-31. PubMed ID: 8759722
[TBL] [Abstract][Full Text] [Related]
12. Bacterial superantigens reactivate antigen-specific CD8+ memory T cells.
Coppola MA; Blackman MA
Int Immunol; 1997 Sep; 9(9):1393-403. PubMed ID: 9310843
[TBL] [Abstract][Full Text] [Related]
13. The role of IL-4 in the staphylococcal enterotoxin B-triggered immune response: increased susceptibility to shock and deletion of CD8Vbeta8+ T cells in IL-4 knockout mice.
Aroeira LS; Martínez-A C
Eur J Immunol; 1999 Apr; 29(4):1397-405. PubMed ID: 10229108
[TBL] [Abstract][Full Text] [Related]
14. Induction of responsiveness in superantigen-induced anergic T cells. Role of ligand density and costimulatory signals.
Heeg K; Wagner H
J Immunol; 1995 Jul; 155(1):83-92. PubMed ID: 7602125
[TBL] [Abstract][Full Text] [Related]
15. Activation and re-activation potential of T cells responding to staphylococcal enterotoxin B.
Hamel ME; Eynon EE; Savelkoul HF; van Oudenaren A; Kruisbeek AM
Int Immunol; 1995 Jul; 7(7):1065-77. PubMed ID: 8527404
[TBL] [Abstract][Full Text] [Related]
16. Repeated treatment with antibody-targeted superantigens strongly inhibits tumor growth.
Rosendahl A; Kristensson K; Hansson J; Ohlsson L; Kalland T; Dohlsten M
Int J Cancer; 1998 Apr; 76(2):274-83. PubMed ID: 9537591
[TBL] [Abstract][Full Text] [Related]
17. Active suppression induced by cutaneous exposure to bacterial superantigen is prevented by interleukin-12 treatment in vivo.
Saloga J; Enk AH; Becker D; Bellinghausen I; Kühn S; Knop J
Immunology; 1998 Apr; 93(4):485-92. PubMed ID: 9659219
[TBL] [Abstract][Full Text] [Related]
18. Superantigen-reactive T cells that display an anergic phenotype in vitro appear functional in vivo.
Heeg K; Gaus H; Griese D; Bendigs S; Miethke T; Wagner H
Int Immunol; 1995 Jan; 7(1):105-14. PubMed ID: 7718507
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
Rich S; Seelig M; Lee HM; Lin J
J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
[TBL] [Abstract][Full Text] [Related]
20. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
Sundstedt A; Grundström S; Dohlsten M
Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]